CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 135 filers reported holding CARA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $414,296 | 0.0% | 84,378 | 0.0% | 0.00% | – |
Q1 2023 | $414,296 | -54.3% | 84,378 | 0.0% | 0.00% | – |
Q4 2022 | $906,221 | -99.9% | 84,378 | +0.6% | 0.00% | – |
Q3 2022 | $784,977,000 | +53.8% | 83,865 | +50.0% | 0.00% | – |
Q2 2022 | $510,541,000 | -24.9% | 55,919 | 0.0% | 0.00% | – |
Q1 2022 | $679,416,000 | -0.2% | 55,919 | 0.0% | 0.00% | – |
Q4 2021 | $681,094,000 | -21.2% | 55,919 | 0.0% | 0.00% | – |
Q3 2021 | $863,949,000 | -0.3% | 55,919 | -7.9% | 0.00% | – |
Q2 2021 | $866,802,000 | -34.1% | 60,743 | +0.3% | 0.00% | -100.0% |
Q1 2021 | $1,315,322,000 | +45.9% | 60,586 | +1.7% | 0.00% | – |
Q4 2020 | $901,430,000 | +18.9% | 59,579 | 0.0% | 0.00% | – |
Q3 2020 | $758,142,000 | +27.0% | 59,579 | +70.6% | 0.00% | – |
Q2 2020 | $597,013,000 | +42.4% | 34,913 | +10.0% | 0.00% | – |
Q1 2020 | $419,139,000 | -22.9% | 31,729 | -6.0% | 0.00% | – |
Q4 2019 | $543,938,000 | -7.2% | 33,764 | +5.3% | 0.00% | – |
Q3 2019 | $586,003,000 | +63.6% | 32,057 | +92.4% | 0.00% | – |
Q2 2019 | $358,190,000 | -36.2% | 16,660 | -41.7% | 0.00% | – |
Q1 2019 | $561,114,000 | +234.9% | 28,599 | +121.9% | 0.00% | – |
Q4 2018 | $167,544,000 | -66.8% | 12,888 | -38.9% | 0.00% | – |
Q3 2018 | $505,345,000 | +25.1% | 21,100 | 0.0% | 0.00% | – |
Q2 2018 | $404,065,000 | -79.3% | 21,100 | -85.2% | 0.00% | -100.0% |
Q3 2017 | $1,952,386,000 | -11.0% | 142,614 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $2,194,829,000 | -58.2% | 142,614 | -50.1% | 0.00% | -60.0% |
Q1 2017 | $5,250,897,000 | +7837059.7% | 285,530 | +2543.8% | 0.01% | – |
Q1 2016 | $67,000 | -63.2% | 10,800 | 0.0% | 0.00% | – |
Q4 2015 | $182,000 | – | 10,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,647,473 | $24,780,000 | 2.96% |
Chescapmanager LLC | 1,160,392 | $10,861,000 | 2.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,333,000 | $12,477,000 | 1.60% |
Altium Capital Management LP | 193,000 | $1,806,000 | 0.66% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,700,230 | $15,914,000 | 0.44% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 171,423 | $1,605,000 | 0.22% |
Lisanti Capital Growth, LLC | 159,225 | $1,490,000 | 0.20% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,529 | $679,000 | 0.15% |
PINNACLE ASSOCIATES LTD | 705,367 | $6,602,000 | 0.15% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $23,400,000 | 0.13% |